Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adma Biologics (NQ: ADMA )

3.670 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,518,835
Open 3.700
Bid (Size) 3.660 (1)
Ask (Size) 3.700 (7)
Prev. Close 3.670
Today's Range 3.620 - 3.740
52wk Range 1.300 - 3.980
Shares Outstanding 196,357,149
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance
From ADMA Biologics, Inc.
Via Globe NewsWire
Jim Cramer Says Forget AT&T, This 'Class Of The Field' Communications Stock Is Better
On CNBC’s "Mad Money Lightning Round," Jim Cramer said ADMA Biologics, Inc. (NASDAQ: ADMA) is a "great spec, but it is losing money hand over fist. I think it’s very binary. 
Via Benzinga

Performance

YTD
-5.17%
-5.17%
1 Month
-0.27%
-0.27%
3 Month
+30.14%
+30.14%
6 Month
+71.50%
+71.50%
1 Year
+169.85%
+169.85%

More News

Read More
Bulls In A Bear Market: These 10 Stocks Clocked Gains In Excess Of 100% In 2022
Via Benzinga
Looking Into ADMA Biologics's Return On Capital Employed
Via Benzinga
Recap: ADMA Biologics Q2 Earnings
Via Benzinga
ADMA Biologics Announces FDA Approval for Room Temperature Storage of ASCENIV™ & BIVIGAM®
From ADMA Biologics, Inc.
Via Globe NewsWire
ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
From ADMA Biologics, Inc.
Via Globe NewsWire
ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock
From ADMA Biologics, Inc.
Via Globe NewsWire
ADMA Biologics Announces Proposed Public Offering of Common Stock
From ADMA Biologics, Inc.
Via Globe NewsWire
ADMA Biologics Announces Preliminary Fourth Quarter 2022 Revenue Estimate
From ADMA Biologics, Inc.
Via Globe NewsWire
Why Cano Health Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket
Via Benzinga
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
Via Benzinga
Why Magnite Shares Are Trading Higher By Over 45%? Here Are 69 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Coupang, Rivian Automotive And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
ADMA Biologics Announces Third Quarter 2022 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via Globe NewsWire
A Preview Of ADMA Biologics's Earnings
Via Benzinga
ADMA Biologics to Report Third Quarter 2022 Financial Results on November 9, 2022
From ADMA Biologics, Inc.
Via Globe NewsWire
ADMA BioCenters Receives FDA Approval for its Seventh Plasma Collection Center, Located in Greensboro, NC
From ADMA Biologics, Inc.
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
Via Benzinga
7 A-Rated Stocks to Buy for Less Than $10
Via InvestorPlace
7 Top-Rated Biotech Stocks to Buy for Q4
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Stocks That Made New Highs On Friday, Aug. 19
Via Talk Markets
ADMA Biologics: Earnings Outlook
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.